UK markets close in 2 hours 3 minutes

Anhui Anke Biotechnology (Group) Co., Ltd. (300009.SZ)

Shenzhen - Shenzhen Delayed price. Currency in CNY
Add to watchlist
10.14-0.03 (-0.29%)
At close: 03:04PM CST
Currency in CNY

Valuation measures4

Market cap (intra-day) 17.05B
Enterprise value 15.53B
Trailing P/E 19.19
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)5.76
Price/book (mrq)4.30
Enterprise value/revenue 5.30
Enterprise value/EBITDA 16.17

Trading information

Stock price history

Beta (5Y monthly) 0.52
52-week change 3-0.10%
S&P500 52-week change 328.04%
52-week high 311.77
52-week low 37.56
50-day moving average 39.94
200-day moving average 39.91

Share statistics

Avg vol (3-month) 320.11M
Avg vol (10-day) 343.26M
Shares outstanding 51.68B
Implied shares outstanding 61.68B
Float 81B
% held by insiders 138.66%
% held by institutions 18.60%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 40.25
Forward annual dividend yield 42.46%
Trailing annual dividend rate 30.25
Trailing annual dividend yield 32.46%
5-year average dividend yield 41.52
Payout ratio 447.17%
Dividend date 3N/A
Ex-dividend date 419 May 2023
Last split factor 21.2:1
Last split date 314 May 2021

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 30.04%
Operating margin (ttm)37.62%

Management effectiveness

Return on assets (ttm)12.26%
Return on equity (ttm)22.90%

Income statement

Revenue (ttm)2.93B
Revenue per share (ttm)1.76
Quarterly revenue growth (yoy)10.40%
Gross profit (ttm)N/A
EBITDA 1.04B
Net income avi to common (ttm)879.36M
Diluted EPS (ttm)0.53
Quarterly earnings growth (yoy)17.30%

Balance sheet

Total cash (mrq)1.58B
Total cash per share (mrq)0.94
Total debt (mrq)54.22M
Total debt/equity (mrq)1.30%
Current ratio (mrq)3.17
Book value per share (mrq)2.37

Cash flow statement

Operating cash flow (ttm)891.72M
Levered free cash flow (ttm)539.13M